cancer drug

Is chronic fatigue syndrome triggered by defective immune system?

Researchers exploring the causes of Chronic Fatigue Syndrome (CFS) believe a faulty immune system attacking the body may be the culprit.

Doctors found, rituximab, a cancer drug that suppresses the immune system helped alleviate symptoms of CFS in some patients.

Cancer drug shows promise in preventing heart failures

A novel Texas study has proposed that a cancer drug, a type of histone deacetylase (HDAC) inhibitor, may help in averting heart attack risks caused by high blood pressures.

According to the study, the promising drug helps in reversing adverse effects of the natural process of autophagy in heart muscle.

Joseph Hill, chief of cardiology at the University of Texas Southwestern Medical Centre and his colleagues initiated the study in mice and said, “Autophagy is a natural process by which cells eat their own proteins to provide needed resources in times of stress.”

Cancer drug shows promise in treating spinal injuries--study

In what could pave the way towards a new treatment for nerve cell regeneration after spinal cord injuries, researchers claim the cancer drug Taxol, has the potential to repair damaged nerve membranes of the spinal region and restore their ability to transmit signals to the brain.

Taxol (1).jpg

After spinal cord injuries, many factors halt the regeneration of nerve cells, which are networks of neurons in the spinal region that are thought to produce an automatic walking motion.

According to experts, re-growth of nerve cells, known as axons is halted because of the formation of scar tissue and the blockage of microtubules, small protein tubes in the cell cytoskeleton.

The researchers found that the drug Taxol when given to rats with spinal injury targeted the damaged sensory neurons.

Syndicate content